A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
复制标题
改善小鼠胆道闭锁综合征的银纳米颗粒方法。
DOI:
10.3791/58158
复制
发表时间:
2018-10-01
影响因子:
1.2
通讯作者:
Zhang, Ruizhong
中科院分区:
文献类型:
--
作者:
Fu, Ming;Lin, Zefeng;Zhang, Ruizhong
Biliary atresia (BA) is a severe type of cholangitis with high mortality in children of which the etiology is still not fully understood. Viral infections may be one possible cause. The typical animal model used for studying BA is established by inoculating a neonatal mouse with a rhesus rotavirus. Silver nanoparticles have been shown to exert antibacterial and antiviral effects; their function in the BA mouse model is evaluated in this study. Currently, in BA animal experiments, the methods used to improve the symptoms of BA mice are generally symptomatic treatments given via food or other drugs. The aim of this study is to demonstrate a new method for ameliorating BA syndrome in mice by the intraperitoneal injection of silver nanoparticles and to provide detailed methods for preparing the silver nanoparticle gel formulation. This method is simple and widely applicable and can be used to research the mechanism of BA, as well as in clinical treatments. Based on the BA mouse model, when the mice exhibit jaundice, the prepared silver nanoparticle gel is injected intraperitoneally to the surface of the lower liver. The survival status is observed, and biochemical indicators and liver histopathology are examined. This method allows a more intuitive understanding of both the establishment of the BA model and novel BA treatments.